Prophylaxis of hereditary breast cancer

por de Groot, Jolien S., van Diest, Paul J., Derksen, Patrick W.B.
Publicado 2017

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection

por de Groot, Jolien S., Moelans, Cathy B., Elias, Sjoerd G., Fackler, Mary Jo, van Domselaar, Robert, Suijkerbuijk, Karijn P.M., Witkamp, Arjen J., Sukumar, Saraswati, van Diest, Paul J., van der Wall, Elsken
Publicado 2016

αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer

por de Groot, Jolien S, Ratze, Max AK, van Amersfoort, Miranda, Eisemann, Tanja, Vlug, Eva J, Niklaas, Mijanou T, Chin, Suet‐Feung, Caldas, Carlos, van Diest, Paul J, Jonkers, Jos, de Rooij, Johan, Derksen, Patrick WB
Publicado 2018

Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice

por de Groot, Jolien S., van Diest, Paul J., van Amersfoort, Miranda, Vlug, Eva J., Pan, Xiaojuan, ter Hoeve, Natalie D., Rosing, Hilde, Beijnen, Jos H., Youssef, Sameh A., de Bruin, Alain, Jonkers, Jos, van der Wall, Elsken, Derksen, Patrick W.B.
Publicado 2017

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis

por van de Ven, Robert A.H., de Groot, Jolien S., Park, Danielle, van Domselaar, Robert, de Jong, Danielle, Szuhai, Karoly, van der Wall, Elsken, Rueda, Oscar M., Ali, H. Raza, Caldas, Carlos, van Diest, Paul J., Hetzer, Martin W., Sahai, Erik, Derksen, Patrick W.B.
Publicado 2016

Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis

por van de Ven, Robert A. H., de Groot, Jolien S., Park, Danielle, van Domselaar, Robert, de Jong, Danielle, Szuhai, Karoly, van der Wall, Elsken, Rueda, Oscar M., Ali, H. Raza, Caldas, Carlos, van Diest, Paul J., Hetzer, Martin W., Sahai, Erik, Derksen, Patrick W. B.
Publicado 2017